PhRMA Chair Urges Japan to Maintain On-Patent Drug Prices, Improve Initial Pricing

PhRMA Chair Vas Narasimhan Japan should maintain the prices of patented medicines and improve the initial price-setting to better capture the value of innovation while pruning spending on older drugs, Vas Narasimhan, the chair of the Pharmaceutical Research and Manufacturers...read more